BIOMAT Database Logo BIOMAT Database Logo

[Late results of 12-month-long hospital treatment of chronic pulmonary tuberculosis with rifampicin combined with other antitubercular agents]. 1977

R Danilczuk, and K Piekarniak, and M Wyczólkowski, and K Martyniak

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006760 Hospitalization The confinement of a patient in a hospital. Hospitalizations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular

Related Publications

R Danilczuk, and K Piekarniak, and M Wyczólkowski, and K Martyniak
[Early results of rifampicin treatment combined with other antitubercular agents in patients with recent and chronic pulmonary tuberculosis].
February 1979, Pneumonologia polska,
R Danilczuk, and K Piekarniak, and M Wyczólkowski, and K Martyniak
[Rifampicin combined with ethambutol and other antitubercular agents in the treatment of patients with chronic pulmonary tuberculosis. Early results. II. Analysis of causes of treatment interruption].
February 1976, Pneumonologia polska,
R Danilczuk, and K Piekarniak, and M Wyczólkowski, and K Martyniak
[Late results of treatment of chronic pulmonary tuberculosis with rifampicin].
July 1973, Gruzlica i choroby pluc; tuberculosis et pneumonologia,
R Danilczuk, and K Piekarniak, and M Wyczólkowski, and K Martyniak
[Rifampicin combined with ethambutol and other antitubercular drugs in the treatment of patients with pulmonary tuberculosis. Early results. I. Bacteriological evaluation].
January 1976, Pneumonologia polska,
R Danilczuk, and K Piekarniak, and M Wyczólkowski, and K Martyniak
[Long-term results of treatment with rifampicin in early pulmonary tuberculosis].
January 1972, Archivio Monaldi per la tisiologia e le malattie dell'apparato respiratorio,
R Danilczuk, and K Piekarniak, and M Wyczólkowski, and K Martyniak
Combined treatment with rifampicin-ethambutol-capreomycin in chronic open pulmonary tuberculosis.
January 1969, Acta tuberculosea et pneumologica Belgica,
R Danilczuk, and K Piekarniak, and M Wyczólkowski, and K Martyniak
[Late results of treatment with rifampicin combined with SM and INH in newly detected cases of pulmonary tuberculosis].
March 1976, Pneumonologia polska,
R Danilczuk, and K Piekarniak, and M Wyczólkowski, and K Martyniak
[Results of intermittent treatment with antitubercular agents in cavernous pulmonary tuberculosis in adults].
January 1976, Revista de igiena, bacteriologie, virusologie, parazitologie, epidemiologie, pneumoftiziologie. Pneumoftiziologia,
R Danilczuk, and K Piekarniak, and M Wyczólkowski, and K Martyniak
[Early results of treatment of patients with chronic pulmonary tuberculosis with rifampicin].
May 1974, Gruzlica i choroby pluc; tuberculosis et pneumonologia,
R Danilczuk, and K Piekarniak, and M Wyczólkowski, and K Martyniak
[Late results of treatment of patients with drug resistant bacilli with ethionamide and other antitubercular agents].
October 1968, Gruzlica i choroby pluc; tuberculosis et pneumonologia,
Copied contents to your clipboard!